Thursday September 9, 2010
Generic Drug Submissions & Approval
Preparing for Legal and Regulatory Requirements
April 20-21, 2010 - New Jersey, USA

A Regulatory Affairs Course with Comprehensive & Interactive Discussions on:

  • Guidance and Requirements for ANDA/ANDS Approval
  • Brand versus Generic Legal Issues
  • Trade Dress Requirements
  • European Registration System for Generics
  • Impact of New EC Laws on Data Exclusivity
  • INDIA and CHINA - Emerging Generic Strategies
  • How to Submit a Quality Dossier to Reduce Approval Time
  • The 505(b)(2) Application and Approval Route
  • Forfeiture of 180-day Exclusivity
  • Legal Challenges to the 505(b)(2) Process
  • Labeling Requirements for ANDA/ANDS Approval
  • Post-Approval Reporting Requirements for ANDA Amendments
  • Field Alerts and Deviation Reports
  • The DMF Filing as Part of the Drug Submission

Workshop:

  • Preparing a Regulatory Submission in CTD Format
Information to be posted shortly
Information to be posted shortly

This two day conference is directed towards Directors, Managers, supervisors, and Associates in the Pharmaceutical, Biopharmaceutical and allied industries with responsibilities in:

  • Regulatory Affairs
  • Quality Assurance
  • Drug Development
  • Submissions
  • Product Registration
  • Product Development
  • Project Management
  • Clinical Research
  • Compliance
  • Documentation and Technical Writing
  • Electronic Submissions
  • Training
Registration opening soon
Please contact us for more information, you may fill in form below.
First Name: Last Name:
Title/Position: Company:
Contact Email: Contact Phone: Fax Number:
Inquiry:

Information to be posted shortly
Copyright © 2010 www.ipacanada.com - International Pharmaceutical Academy - All Rights Reserved.